Condition · ICD-10 G30.9
Alzheimer's Disease
Alzheimer's Disease
A progressive neurological disorder that causes the brain to shrink and brain cells to die, leading to memory loss and cognitive decline.
Alzheimer's disease is the most common cause of dementia, accounting for 60–80% of cases. Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine provide modest symptomatic benefit. Novel anti-amyloid therapies (lecanemab, aducanumab) are emerging disease-modifying options.
At a glance
Medications tracked
7
First-line options
Donepezil hydrochloride, Memantine hcl, Rivastigmine tartrate, Galantamine hydrobromide
Related conditions
DementiaParkinson DiseaseVascular DementiaDepression
First-line Related Treatments
Commonly associated primary options — verify with your clinician
Short-term / As-needed
Related options for acute or bridging use
Situational
Related options for specific presentations
Top treatments tried for Alzheimer's Disease
Community-driven data · early preview
Donepezil hydrochloride
1,800 people tried
★★★★★4.3
Memantine hcl
1,520 people tried
★★★★★4.1
Rivastigmine tartrate
1,240 people tried
★★★★★4.0
Galantamine hydrobromide
960 people tried
★★★★★3.8
Help build the dataset — log treatments you've tried, rate what helped, and report side effects.